Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · Real-Time Price · USD

0.805115

-0.0063 (-0.77%)

At close: Sep 30, 2026, 4:00 PM EDT

0.7300

-0.0751 (-9.33%)

After-hours: Sep 30, 2026, 7:59 PM EDT

Clearmind Medicine Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Net Income	-7.5	-3.86	-5.25	-8.62	-6.89	-3
Depreciation & Amortization	0.05	0.05	0.05	0.06	0.08	0.01
Loss (Gain) From Sale of Investments	-1.94	-0.84	0.07	0.11	0.31	-
Stock-Based Compensation	1.79	0.81	1	0.83	1.21	0.68
Other Operating Activities	0.86	-0.85	-0.59	2.29	0.33	-
Change in Accounts Receivable	-0.11	0.02	0.06	-0.15	0.02	-0.13
Change in Accounts Payable	0	0.08	-0.2	-0.62	0.91	0.28
Change in Other Net Operating Assets	-0.24	-0.14	0	-0.19	0.3	-0.13
Operating Cash Flow	-7.07	-4.73	-4.86	-6.3	-3.72	-2.29
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Capital Expenditures	-	-	-	-	-0.01	-0.03
Sale (Purchase) of Intangibles	-	-	-	-	-	-0.16
Investment in Securities	-1.5	-0.53	-0.27	-	-	-
Other Investing Activities	-	-0.01	0.03	-0.03	-	-0.02
Investing Cash Flow	-1.95	-0.54	-0.24	-0.03	-0.01	-0.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Long-Term Debt Issued	-	2.25	-	-	-	-
Long-Term Debt Repaid	-	-0.04	-0.04	-0.04	-0.07	-
Lease Payments	-0.05	-0.04	-0.04	-0.04	-0.07	-
Net Debt Issued (Repaid)	10.08	2.21	-0.04	-0.04	-0.07	-
Issuance of Common Stock	7.49	0.42	6.3	11.71	0.58	5.93
Financing Cash Flow	17.57	2.62	6.25	11.66	0.51	5.93

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Foreign Exchange Rate Adjustments	-0.01	0	-0.01	-0.04	-0.02	-
Net Cash Flow	8.54	-2.65	1.15	5.3	-3.24	3.44

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Free Cash Flow	-7.07	-4.73	-4.86	-6.3	-3.73	-2.31
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-13.96	-372.53	-	-	-	-
Levered Free Cash Flow	-4.78	-3.82	-3.13	-0.15	-0.88	-1.33
Unlevered Free Cash Flow	-4.78	-3.81	-3.11	-0.14	-0.87	-1.33
Free Cash Flow After Leases	-7.12	-4.78	-4.9	-6.34	-3.8	-2.31

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash Interest Paid	0	0	0.01	0	0.01	-
Cash Income Tax Paid	0.08	0.23	0.31	0.01	-	-
Change in Working Capital	-0.34	-0.04	-0.13	-0.97	1.24	0.02

SEC Filings: 10-K · 10-Q